Nach Davé, ’00, was named vice president of development strategy at Premier Research, a top global clinical research organization. Davé previously led clinical and regulatory affairs at Maxx Orthopedics, a developer of orthopedic medical devices, and has held roles in clinical operations, business development, strategic consulting and medical affairs at companies such as Merck, Bristol-Myers Squibb, Aventis Pharmaceuticals and Mitsubishi Pharma America. Davé is a graduate of LIU’s master’s degree program in drug regulatory affairs, the first such program in North America.
